Shari Wiseman
Shari Wiseman is an American neuroscientist and the editor in chief of Nature Neuroscience.
Education
[edit]Wiseman has two PhDs from Yale University and undertook postdoctoral research at the Beth Israel-Deaconess Medical Center where she worked on animal models of autism spectrum disorders.[1] After that, she undertook postdoctoral training at Tufts University where she focused on the regulation of GABAB receptors by excitotoxic stimuli.[1]
Career
[edit]She has worked at Nature Neuroscience since 2017, as an associate editor, becoming the editor in chief in 2021.[1][2]
Selected publications
[edit]- Senescence in Down syndrome NPCs, Nature Neuroscience, 2022 Feb;25(2):131. doi: 10.1038/s41593-022-01016-6. PMID 35132233
Personal life
[edit]Wiseman lives in New York City.[1] She is a mother of two children.[3]
References
[edit]- ^ a b c d "About the Editors | Nature Neuroscience". www.nature.com. Retrieved 2022-04-04.
- ^ "SEMINAR - Dr. Shari Wiseman - Associate Editor, Nature Neuroscience | The Douglas Research Centre". douglas.research.mcgill.ca. Retrieved 2022-04-06.
- ^ "Twitter biography". Twitter. Retrieved 2022-04-06.
| Authority control databases: Academics |
|---|
 | This article about a neuroscientist is a stub. You can help Wikipedia by expanding it. |
  | This article about a biologist from the United States is a stub. You can help Wikipedia by expanding it. |
 | This biographical article about a print editor of the United States is a stub. You can help Wikipedia by expanding it. |